Download by
Scanning QR Code
No Stock Yet
Stocks That Hit 52-Week Lows On Tuesday
 On Tuesday, 74 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: First Majestic Silver (NYSE:AG) was the biggest company in terms of market cap to set a new 5
Bullfrog AI Holdings, Inc.'s Quiet Period Set To Expire on March 27th (NASDAQ:BFRG)
Bullfrog AI's (NASDAQ:BFRG – Get Rating) quiet period is set to expire on Monday, March 27th. Bullfrog AI had issued 1,297,318 shares in its initial public offering on February 14th. The total size of
Bullfrog AI (NASDAQ:BFRG) Trading Down 2.7%
Shares of Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Rating) fell 2.7% on Wednesday . The company traded as low as $2.75 and last traded at $2.89. 79,610 shares were traded during trading, a decli
BioMarin Pharmaceutical, Aclaris Therapeutics, Esperion Therapeutics Among Premarket Losers' Pack
Bullfrog AI Shares Are Trading Higher in Sympathy With C3.ai, Which Reported Better-than-expected Financial Results and Issued Strong Guidance.
Bullfrog AI shares are trading higher in sympathy with C3.ai, which reported better-than-expected financial results and issued strong guidance.
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers ObsEva SA (NASDAQ:OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.Altamira Therap
Altamira, Bullfrog Top Healthcare Gainers; Praxis, Veru Lead Losers' Pack
MAEK, LPSN and SOUN Are Among Pre Market Gainers
Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Gainers ObsEva SA (NASDAQ:OBSV) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzer
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersBullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 47.6% to $4.03 during Friday's pre-market session. The company's market cap stands at $22.7 million. Rubius Therapeutics (NASDAQ:RUBY) shares
Loading...
No Stock Yet